Literature DB >> 29419381

How to estimate the effect of treatment duration on survival outcomes using observational data.

Miguel A Hernán.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29419381      PMCID： PMC6889975          DOI： 10.1136/bmj.k182

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

2.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

3.  Inverse probability weighting.

Authors:  Mohammad Ali Mansournia; Douglas G Altman
Journal:  BMJ       Date:  2016-01-15

4.  Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.

Authors:  Miguel A Hernán; James M Robins
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

5.  Per-Protocol Analyses of Pragmatic Trials.

Authors:  Miguel A Hernán; James M Robins
Journal:  N Engl J Med       Date:  2017-10-05       Impact factor: 91.245

6.  Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Authors:  Jonathan A C Sterne; Miguel A Hernán; Bruno Ledergerber; Kate Tilling; Rainer Weber; Pedram Sendi; Martin Rickenbach; James M Robins; Matthias Egger
Journal:  Lancet       Date:  2005 Jul 30-Aug 5       Impact factor: 79.321

7.  The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening.

Authors:  Xabier García-Albéniz; John Hsu; Miguel A Hernán
Journal:  Eur J Epidemiol       Date:  2017-07-26       Impact factor: 8.082

8.  Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model.

Authors:  Stephen R Cole; Miguel A Hernán; Kathryn Anastos; Beth D Jamieson; James M Robins
Journal:  Am J Epidemiol       Date:  2007-05-02       Impact factor: 4.897

9.  Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer.

Authors:  Louise Emilsson; Xabier García-Albéniz; Roger W Logan; Ellen C Caniglia; Mette Kalager; Miguel A Hernán
Journal:  JAMA Oncol       Date:  2018-01-01       Impact factor: 31.777

10.  Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.

Authors:  Lauren E Cain; Michael S Saag; Maya Petersen; Margaret T May; Suzanne M Ingle; Roger Logan; James M Robins; Sophie Abgrall; Bryan E Shepherd; Steven G Deeks; M John Gill; Giota Touloumi; Georgia Vourli; François Dabis; Marie-Anne Vandenhende; Peter Reiss; Ard van Sighem; Hasina Samji; Robert S Hogg; Jan Rybniker; Caroline A Sabin; Sophie Jose; Julia Del Amo; Santiago Moreno; Benigno Rodríguez; Alessandro Cozzi-Lepri; Stephen L Boswell; Christoph Stephan; Santiago Pérez-Hoyos; Inma Jarrin; Jodie L Guest; Antonella D'Arminio Monforte; Andrea Antinori; Richard Moore; Colin Nj Campbell; Jordi Casabona; Laurence Meyer; Rémonie Seng; Andrew N Phillips; Heiner C Bucher; Matthias Egger; Michael J Mugavero; Richard Haubrich; Elvin H Geng; Ashley Olson; Joseph J Eron; Sonia Napravnik; Mari M Kitahata; Stephen E Van Rompaey; Ramón Teira; Amy C Justice; Janet P Tate; Dominique Costagliola; Jonathan Ac Sterne; Miguel A Hernán
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 9.685
View more
  23 in total

1.  Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.

Authors:  Tom Greene; Jian Ying; Edward F Vonesh; Hocine Tighiouart; Andrew S Levey; Josef Coresh; Jennifer S Herrick; Enyu Imai; Tazeen H Jafar; Bart D Maes; Ronald D Perrone; Lucia Del Vecchio; Jack F M Wetzels; Hiddo J L Heerspink; Lesley A Inker
Journal:  J Am Soc Nephrol       Date:  2019-07-10       Impact factor: 10.121

2.  A Prospective Cohort Study of Durations of Staphylococcus aureus Bacteremia According to Different Phenotypes and a New Concept of Persistent Bacteremia.

Authors:  Chang Kyung Kang; Kyoung-Ho Song; Seong Eun Kim; Eu Suk Kim; Wan Beom Park; Kyung-Hwa Park; Shin Hye Chun; Shinwon Lee; Chong Rae Cho; Seung Ji Kang; Myoung-Don Oh; Yeon-Sook Kim; Sun Hee Lee; Yee Gyung Kwak; Hee-Chang Jang; Chung-Jong Kim; Young Keun Kim; Ji-Hwan Bang; Sungmin Kiem; Ki Tae Kwon; Younghee Jung; Yu Min Kang; Sook-In Jung; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

3.  The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study.

Authors:  Gregory McDermott; Xiaoqing Fu; Claire Cook; Catherine Ahola; Brett Doliner; Jennifer Hanberg; John H Stone; Hyon K Choi; Yuqing Zhang; Zachary S Wallace
Journal:  Ann Rheum Dis       Date:  2022-06-13       Impact factor: 27.973

4.  Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.

Authors:  Dag Holmberg; Fredrik Mattsson; Shaohua Xie; Eivind Ness-Jensen; Hashem El-Serag; Jesper Lagergren
Journal:  J Gastroenterol       Date:  2022-10-18       Impact factor: 6.772

5.  Mortality and morbidity in obstructive sleep apnoea-hypopnoea syndrome: results from a 30-year prospective cohort study.

Authors:  Sophie Dodds; Linda J Williams; Amber Roguski; Marjorie Vennelle; Neil J Douglas; Serafeim-Chrysovalantis Kotoulas; Renata L Riha
Journal:  ERJ Open Res       Date:  2020-09-14

6.  Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial.

Authors:  Felice Gragnano; Marcel Zwahlen; Pascal Vranckx; Dik Heg; Kurt Schmidlin; Christian Hamm; Philippe Gabriel Steg; Giuseppe Gargiulo; Eugene P McFadden; Yoshinobu Onuma; Ply Chichareon; Edouard Benit; Helge Möllmann; Luc Janssens; Sergio Leonardi; Aleksander Zurakowski; Alessio Arrivi; Robert Jan Van Geuns; Kurt Huber; Ton Slagboom; Paolo Calabrò; Patrick W Serruys; Peter Jüni; Marco Valgimigli; Stephan Windecker
Journal:  J Am Heart Assoc       Date:  2022-03-01       Impact factor: 6.106

7.  Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients.

Authors:  Kristin S Weeks; Charles F Lynch; Michele M West; Ryan M Carnahan; Michael A O'Rorke; Jacob J Oleson; Megan E McDonald; Mary E Charlton
Journal:  Am J Clin Oncol       Date:  2021-10-01       Impact factor: 2.787

8.  Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.

Authors:  Liesbet De Bus; Pieter Depuydt; Johan Steen; Sofie Dhaese; Ken De Smet; Alexis Tabah; Murat Akova; Menino Osbert Cotta; Gennaro De Pascale; George Dimopoulos; Shigeki Fujitani; Jose Garnacho-Montero; Marc Leone; Jeffrey Lipman; Marlies Ostermann; José-Artur Paiva; Jeroen Schouten; Fredrik Sjövall; Jean-François Timsit; Jason A Roberts; Jean-Ralph Zahar; Farid Zand; Kapil Zirpe; Jan J De Waele
Journal:  Intensive Care Med       Date:  2020-06-09       Impact factor: 17.440

9.  The effect of treatment delay on time-to-recovery in the presence of unobserved heterogeneity.

Authors:  Nan van Geloven; Theodor A Balan; Hein Putter; Saskia le Cessie
Journal:  Biom J       Date:  2020-01-20       Impact factor: 2.207

Review 10.  Introduction to clinical research based on modern epidemiology.

Authors:  Junichi Hoshino
Journal:  Clin Exp Nephrol       Date:  2020-03-24       Impact factor: 2.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.